Covid-19 Update From Cycle Regarding Nityr
Covid-19 Update From Cycle Regarding Nityr At Cycle Pharmaceuticals, the health and safety of patients with tyrosinemia type 1 (HT-1) is our top priority. As the Coronavirus increases in worldwide prevalence, please have full confidence that the supply chain for NITYR® (nitisinone) Tablets is fully organized and managed to serve patients with HT-1 and their […]
Covid-19 Update From Cycle Regarding Nityr Read More »





